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The purpose of this article is to provide background about the United 
States Food and Drug Administration (FDA).  The article will focus 
particularly upon the agency's authority, its place in the United 
States system, and its history as a domestic institution and as a 
participant in international activities.  Finally, the article 
summarizes principal areas of regulatory cooperation with the 
European Union in the foods area and outlines future areas of 
cooperation. 
 
The article may be of interest to counterparts in other countries, 
confronted with such food safety issues - particularly the recent 
evidence that humans might develop a variant of a fatal neurological 
disease (Creutzfeld-Jakob disease) as a result of eating beef from 
cattle afflicted with bovine spongiform encephalopathy (BSE). 
 
I.  FDA's Role
 
FDA is a component of the Department of Health and Human Services 
but traditionally has functioned with a high degree of independence 
(but, at the same time, with many checks and balances, or 
"safeguards," to assure public accountability and prevent official 
abuse of authority).   
 
FDA's regulatory autonomy rests upon three pillars:   strong legal 
underpinnings, a solid basis in science and public health protection 
for its decisions, and support of the public. 
 
oConcerning the legal underpinnings, FDA administers and enforces 
comprehensive laws to assure that food and cosmetics are 
safe, that pharmaceuticals and medical devices have been 
shown by the manufacturer to be safe and effective, and 
that all products are properly labeled.  Its institutional 
semi-autonomy is aided by the statutory provisions that 
provide for an agency charter, as well as regulations that 
delegate to the Commissioner (from the Secretary of Health 
and Human Services) virtually all authority under the 
statutes FDA administers.   
 
oFDA's  science  and  public  health  foundation  has,  as  its  core,  a  highly 
expert and dedicated staff of intensely dedicated 
investigators, scientists, physicians, attorneys, 
consumer safety enforcement officers, support staff, and 
leaders  who  are  drawn  to  the  agency,  and  often  stay,  because 
of its compelling mission.  Despite government salaries 
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that  are  not  competitive  with  private  sector  opportunities, 
the agency has gone to great lengths to recruit, reward, 
and retain top-notch people.  Also, the agency maximizes 
outside comments on its decisions by operating in a highly 
transparent manner, through advisory committees and 
frequent meetings and other communications with a diverse 
array  of  groups  including  academics,  health  professionals, 
consumers, and industry.   
 
oSurveys of the American public consistently show that FDA is one 
of the most trusted of American institutions.  A factor 
that strengthens this trust is that the agency's only 
mission is to determine how best to protect the public, 
given the scientific information before it, and the agency 
is supposed to do this even if making the right decision 
means that a company goes out of business or an affected 
industry loses money.  There is not a commingling of public 
protection and economic protection.   
 
Related factors strengthen the agency's legal/scientific/public 
support pillars, including an agency moral compass whose "north" 
is  public  health  protection.    The  agency  has  a  long  history  of  standing 
up to economic or political pressures:  historians can point to 
occasions when these pressures resulted in Congressional action to 
reduce the agency's authority.  (Saccharin and dietary supplements 
are two examples.)   
 
Where these pressures have been applied not through Congress, in 
an attempt to change legislation, but through executive branch 
officials, the agency has likewise been stalwart in maintaining its 
principles.  FDA's history includes a number of incidents, some of 
them from the early years of this century and others from the 1980s, 
in which the agency initially succumbed to these pressures only to 
experience  corrective  action  due  to  lawsuits,  embarrassing  publicity, 
Congressional oversight, or several of these in combination.  The 
history suggests the importance to a country, in the prevention of 
official  abuse,  of  Freedom  of  Information  laws  and  other  transparency, 
consumer groups, and meaningful oversight.  These factors are 
probably even more important than civil service laws, internal 
investigations, inspector general offices, ombudsmen, and integrity 
statutes.   
 
High-level support for science-based decisions also is important. 
 FDA is at its strongest when, as now, it enjoys solid Presidential 
and Secretarial support for the integrity of its decision making. 
 Last, but not least, at crucial points in its history the agency 
has been blessed by effective and charismatic leaders.  Two of the 
best were the first Commissioner, Harvey Washington Wiley, discussed 
below, and the most recent one, David Kessler, whose six years at 
FDA ended on February 28, 1997.   
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The domestic and international regulatory challenge posed by 
BSE-bovine spongiform encephalopathy, or mad cow disease--is only 
one very sobering example of the tough scientific and policy issues 
confronted  by  food  and  veterinary  medicine  regulators  as  this  century 
draws to a close.  Although every indication is that the United States 
is BSE-free, our country is confronting the same difficult issues 
as Europe concerning domestic regulation, importation restrictions, 
and product composition requirements for animal feeds and medicinal 
products.   
 
II.  FDA's Authority
 
FDA has broad authority.
2  It is the sole United States regulatory 
body for pharmaceuticals for human use and for medical devices.  
In the food area, FDA is the principal regulatory body, with some 
authority over all food products.  FDA inspects food establishments 
and ensures compliance through voluntary correction or enforcement 
action, when warranted.  It issues and enforces regulations on good 
manufacturing practices, Hazard Analysis Critical Control Points 
(HACCP), and food labeling.  It approves food and color additives 
and veterinary drugs.   
 
For meat, poultry, and egg products, the Food Safety and Inspection 
Service (FSIS) is the principal United States regulatory body:  it 
is the agency solely responsible for the inspection of meat, poultry, 
and egg products inside "official establishments" where these 
products are processed.  However, where meat, poultry, and egg 
products  are  located  somewhere  other  than  the  official  establishments, 
such as before these animal products reach the official 
establishments, and after the products leave these establishments,
3 
FDA and FSIS share responsibility for them
4 and cooperate on a broad 
                     
     
2 The principal statutes that FDA administers are the Federal 
Food,  Drug,  and  Cosmetic  Act  of  1938,  as  amended  (21  U.S.C.  §§321-393); 
certain  provisions  of  the  Public  Health  Service  Act,  most  importantly 
sections 301, 351, and 361 (42 U.S.C. §§ 241, 262, 264); and the 
Fair Packaging and Labeling Act, 15 U.S.C. §§ 1451-1461).  Other 
statutes administered by FDA are listed in FDA's delegation of 
authority regulations (21 CFR § 5.10). 
     
3 FDA and FSIS share authority to detain meat, poultry, and egg 
products outside official establishments.  21 U.S.C. §§ 679(b), 
467f(b), 1031 et seq. 
     
4 Section 902(a) of the Federal Food, Drug, and Cosmetic Act 
provides that, "Meats and meat food products shall be exempt from 
the provisions of the [Federal Food, Drug, and Cosmetic] Act to the 
extent of the application...of the Meat Inspection Act," 21 U.S.C. 
§ 392. "Notwithstanding any other provisions of law, including [21 
U.S.C. §392(b)], the provisions of [the Federal Meat Inspection] 
Act shall not derogate from any authority conferred by the Federal  
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range of enforcement activities.  Also, FDA regulates any food 
additives used in meat or poultry (e.g., nitrites in ham), decides 
whether to allow radiation of meat and poultry, and approves animal 
drugs used in food-producing animals.  Thus, Congress wrote the laws 
on  food  in  general,  and  meat,  poultry,  and  egg  products  in  particular, 
so as to avoid regulatory gaps:  FDA has broad, residual authority 
that resumes wherever FSIS authority ends.  The Animal and Plant 
Health Inspection Service (APHIS) also administers laws aimed at 
curbing spread of animal and plant disease.  (Other agencies with 
responsibilities of food are described in Appendix 1.) 
 
The  50  States  of  the  United  States,  as  well  as  the  District  of  Columbia, 
Puerto Rico, and territories, also have public health protection 
activities in the food area, particularly concerning retail sales 
(such  as  restaurants,  supermarkets,  hospital  and  school  cafeterias). 
 FDA's authority over food in interstate and foreign commerce has 
been interpreted very broadly and could encompass even retail 
establishments.  The agency traditionally has preferred to leave 
oversight of such establishments to State (or city or county) 
governments and to confine its own compliance activities over such 
establishments to issuance of uniform guidance on desirable 
sanitation practices.   
 
 
Food Drug, and Cosmetic Act prior to enactment of the Wholesome Meat 
Act."  21 U.S.C. §679(a).  "Poultry and poultry products shall be 
exempt from the provisions of the Federal Food, Drug, and Cosmetic 
Act to the extent of the application or extension thereto of the 
provisions of this act, except that the provisions of [the Wholesome 
Poultry  Products]  Act  shall  not  derogate  from  any  authority  conferred 
by the Federal Food, Drug, and Cosmetic Act prior to the enactment 
of the Wholesome Poultry Products Act."  21 U.S.C. §467f(a).  The 
provisions of [the Egg Products Inspection] Act shall not affect 
the applicability of the Federal Food, Drug, and Cosmetic Act...or 
other laws...except that the Secretary of Agriculture shall have 
exclusive jurisdiction to regulate official plants processing egg 
products and operations thereof as to all matters within the scope 
of this Act."  21 U.S.C. §1041.    
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III. FDA's History
 
A.  When Was FDA Created?   
 
The seemingly simple question of when FDA was founded is difficult 
to answer:
5
 
oWas it 1883, when Harvey Wiley, the father of United States national 
food and drug legislation, was appointed to head the 
chemistry unit
6 of the Department of Agriculture? 
 
oWas it 1899, when that unit first obtained enforcement authority, 
albeit only over imports? 
 
oWas it 1906, when the famous Food and Drugs Act of 1906 was passed, 
giving the Bureau of Chemistry authority for the first 
time over food and drugs generally?
7   
 
oWas it 1927, when the Bureau of Chemistry was renamed the Food, 
Drug, and Insecticide Administration? 
 
oWas it 1930, when the agency was given its current name, the Food 
and Drug Administration?
8
 
oOr was it 1988, when Congress finally provided the agency with a 
statutory charter in the Food and Drug Administration Act? 
                     
     
5 The author favors observance of the agency's birthday as March 
1, 1899, when its legal mandate began, a date that offers the 
opportunity for a centennial celebration soon, and on the eve of 
the next millennium.  FDA could still celebrate the centennial of 
the Food and Drugs Act in 2006, of the "FDA" name in 2030, of the 
Federal Food, Drug, and Cosmetic Act in 2038, and so forth. 
     
6 The name of the unit was Division of Chemistry from 1883 until 
1903,  then  Bureau  of  Chemistry  from  1903  until  1927.    Hutt  and  Merrill, 
Food and Drug Law:  Cases and Materials, at 4. 
     
7 On the same day, the Meat Inspection Act was enacted, a law 
inspired by insanitary conditions in meat packing plants as 
publicized in Upton Sinclair's The Jungle-and assigned not to the 
Bureau of Chemistry but the Bureau of Animal Husbandry.  This split 
between  regulatory  handling  of  meat,  and  regulatory  handling  of  other 
foods, continues to this day. 
         
8  Angry  farmers'  protests  concerning  agency  restrictions  on  certain 
pesticides led Congress to strip the agency of its powers over these 
products.  The authority was moved to another part of the Department 
of Agriculture, then to the Environmental Protection Agency in 1970. 
 Reorganization Plan No. 2 (1970).  
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 B.Landmarks in Food Regulation History
 
FDA's early history, with an emphasis on statutes empowering the 
agency to regulate food, international activities, and parallel 
events  in  the  early  life  of  the  meat  and  poultry  program,  is  summarized 
in Appendix 2.   
 
Turning to modern history, watershed events that brought FDA's food 
program to where it is today include the following highlights in 
its in the agency's organizational, legal, and regulatory history: 
 
othe Federal Food, Drug, and Cosmetic Act of 1938; 
 
oFDA's  move  from  the  Department  of  Agriculture  to  the  Federal  Security 
Administration in 1939; 
 
othe Supreme Court's 1943 Dotterweich decision, holding corporate 
executives strictly liable for criminal prosecution due 
to violations of the Act, without need for the government 
to prove knowledge or intent; 
 
othe upgrading of the Federal Security Administration to the 
Department of Health, Education, and Welfare in 1953; 
 
othe "enforcement era" of the 1940s, 50s, and 60s, in which FDA 
emphasized law enforcement and brought many court cases 
that resulted in judicial decisions upholding a 
pro-consumer protection interpretation of the law; 
 
othe enactment of new authorities over pesticides, food additives, 
and color additives in 1954, 1958, and 1960 respectively, 
heralding a move from after-the-fact enforcement to the 
"preventive era;" 
 
othe creation of the Codex Alimentarius Commission in 1962, which 
began an era of international cooperation;
9  
                     
     
9 In 1962 the Codex Alimentarius Commission was founded as a 
joint activity of the World Health Organization (WHO) and the Food 
and Agricultural Organization (FAO) of the United Nations (UN) to 
establish international food standards. Depew, The Joint FAO-WHO 
Conference on Food Standards, 18 Food Drug Cosmetic Law Journal 34 
(1963); J.P. Frawley, Codex Alimentarius--Food Safety--Pesticides, 
42 Food Drug Cosmetic Law Journal 168 (1987).  FDA's Deputy 
Commissioner, John Harvey, was instrumental in the founding of Codex 
and served as its first chair.  WHO and FAO had already begun, during 
the 1950s, to hold international consultations on the safety of 
chemicals in food.  C. Feldman, The Food and Drug Administration's 
Redbook:  Toxicological Principles for the Safety Assessment of  
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othe placement of FDA in the Public Health Service in 1968, which 
brought  into  FDA  several  food  programs  for  milk,  shellfish, 
and  interstate  sanitation  previously  carried  out  elsewhere 
in the Service; 
 
othe creation in 1970 of the Bureau of Foods (later the Center for 
Food Safety and Applied Nutrition) and the movement of 
pesticide tolerance-setting to the new Environmental 
Protection Agency that same year; 
 
othe 1972 Bon Vivant vichyssoise botulism poisoning and resultant 
increase in resources for FDA food programs ("Operation 
Hire"); 
 
othe "FDA rulemaking era" of the 1970s, with significant initiatives 
on food labeling, vitamins and minerals, and good 
manufacturing practices and a significant body of court 
opinions upholding a liberal interpretation of FDA's 
authority to fashion the rules it believes necessary to 
carry out the broad purposes of the Act;  
 
othe sweetener and color additive controversies of the 1970s and 
1980s (in which cyclamate, and Red No. 2 and 4 were forced 
off the market, saccharin was saved by Congress from an 
FDA ban, and aspartame and Red No. 40 were approved);  
 
othe creation of the Department of Health and Human Services in 1979; 
 
othe Community Nutrition Institute litigation of the 1980s that 
required rulemaking when the agency gives certain kinds 
of guidance and established FDA's authority to set 
regulatory limits for contaminants through ordinary 
rulemaking (rather than a more burdensome statutory 
procedure that entails a hearing); 
                                                                  
Direct  Food  Additives  and  Color  Additives  Used  in  Food--International 
Implications, 38 Food Drug Cosmetic Law Journal (1982) 368, 371. See 
also FDA Oral History Project, interviews with present or former 
FDA  officials,  William  Horwitz,  July  23,  1983,  at  51-52;  L.W.  Beacham, 
Aug. 28, 1985, at 62; J.W. Cook, June 18, 1980, at 33; and W.V. 
Eisenberg, July 25, 1984, at 38.  
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othe generic drugs bribery scandal of the late 1980s, the consequent 
undermining of both the public's confidence in the agency 
and the pride of the FDA workforce; 
 
oCommissioner Kessler's arrival in 1990 and the seizure of orange 
juice mislabeled as "fresh" (signaling an end to the 
laissez faire regulatory philosophy of the 1980s); 
 
othe enactment of the Nutrition Labeling and Education Act of 1990 
and the Dietary Supplement Act of 1992;  
 
othe United States food agencies' ban on imports of British beef 
and many bovine products after the discovery that bovine 
spongiform encephalopathy (BSE) can develop from cattle 
ingesting feeds with materials from affected animals, and 
FDA's directive to manufacturers to derive bovine 
materials in health products from BSE-free countries; 
  
oapprovals in the mid 1990s of the biotechnology-derived Flavr Savr 
tomato,  bovine  somatotropin  (BST)  to  increase  milk  output, 
and the fat substitute Olestra; 
 
oFDA's strengthening of its program to regulate seafood (after 
prevailing in governmental controversy about which United 
States agency would regulate seafood, with a decision to 
leave the responsibility in FDA rather than move it to 
USDA)  and,  the  development  and  implementation  of  a  landmark 
1995 seafood safety rule;
10
 
othe increased emphasis on international harmonization and 
particularly Codex Alimentarius activities, spurred in 
part by the ratification in 1993 of the North American 
Free Trade Agreement and in 1994 of the World Trade 
Organization Agreements;
11  
 
othe January 1997 proposed ruminant-to-ruminant feed ban; and 
 
othe new attention to infectious disease problems in many countries, 
followed by a range of national and international 
initiatives on food borne illness. 
 
     
10  60 FR 65096 (December 18, 1995). 
     
11 The Uruguay Round Agreements resulted in a new WTO Agreement 
on Sanitary and Phytosanitary Measures (SPS Agreement) that, along 
with an updated Agreement on Technical Barriers to Trade (TBT), are 
intended  to  prevent  member  countries  from  using  technical  regulations 
and food safety and environmental protection measures as disguised 
barriers to trade. "Sanitary" refers to protection of people and 
animals; "phytosanitary" refers to protection of plants.  
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During this era, United States food and drug requirements have been 
highly influential around the world--in international standards 
organizations, when other countries are establishing their own 
requirements, and in day-to-day choices by other countries' 
regulatory officials.    
 
 
IV.  International Harmonization for Food:  the Challenge
 
FDA regards international harmonization as important but difficult. 
 When food crosses international borders, it is expected to meet 
the requirements of the receiving country, which may be different 
from those of the country in which it was produced.  In these 
circumstances, the benefits of uniform food laws for firms in 
international trade are obvious: it is easier to identify what the 
requirements are, and to comply with one set of requirements rather 
than many, some conflicting.   
 
The benefits of uniform food laws to consumers are less obvious, 
but are just as real.  If food laws are not only sufficiently 
protective but uniform--and if uniformity helps producers to 
understand and comply with the law--the food sold to consumers is 
more apt to be safe and properly labeled, and the food may also be 
more economical due to the avoidance of the costs of compliance with 
duplicative regulation or destruction of noncompliant products. 
 
International approaches to assuring food safety are essential 
because imports of food into the United States--and into the European 
Union--have  increased  tremendously.    And  regulatory  agency  resources 
to monitor imports have not kept pace with this deluge of shipments. 
 The growth in imports in relation to our very limited resources 
to inspect them has led FDA to become increasingly interested in 
knowing more about the conditions and regulations in the countries 
sending us these products.  FDA wants to familiarize itself with 
regulatory systems in place in other countries that assure that their 
exports meet our standards. 
 
The difficult phase of aligning FDA standards to those international 
norms that achieve the requisite level of protection--or, as every 
country would prefer, promoting international adoption of one's 
already existing norms--is just beginning.  FDA's standards and 
harmonization policy laid the groundwork (see Appendix 3). 
 
The 1996 Administration Report, Reinventing Food Regulations,
12 
included several international initiatives:  
                     
     
12 National Performance Review, Reinventing Food Regulations, 
January 1996, at 8, 20-21.  
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oHarmonizing requirements with international partners to facilitate 
trade  in  food  commodities  without  compromising  high  United 
States standards of safety; 
 
oAdopting a preventative system for quality control, Hazard Analysis 
and Critical Control Points (HACCP), which has been widely 
adopted as an international standard and by other 
countries;
13
 
oReforming FDA's standards of identity for food, with  adoption of 
international standards as a promising possibility;
14
 
oDeveloping pilot programs to enhance use of private and state or 
local laboratories for analyzing food imports;
15
 
oRelaxing restrictions on exports of animal drugs to countries that 
have approved such drugs for marketing;
16 and 
 
oGranting import tolerances for veterinary drug residues in food, 
whether or not the drug is licensed in the United States.
17
 
The President's recently announced food safety initiative, and the 
budget increase request he submitted to the Congress, will further 
strengthen our program.   
 
The difficulty of the task of harmonizing food regulations should 
not be underestimated.  In the words of one expert, supporters of 
harmonization will "have to win it drop by drop":  and high priority 
choices with some probability of success fall into two areas:  (1) 
hygiene, contaminants, and inspections, and (2) additives, flavors, 
and colors.
18  Impediments to United States-European Union 
harmonization are economic factors (particularly the perception of 
local sellers that harmonization may be less helpful to them than 
 
     
13 Id. at 7-13.  This initiative also involves the Food Safety 
and Inspection Service (FSIS) of the United States Department of 
Agriculture (USDA) with respect to meat and poultry. 
     
14 Id. at 8, 18-19. 
     
15 Id. at 8, 22-23. 
     
16 Id. at 8, 23. 
     
17 Id. at 8, 24. 
     
18 C. Lister, A World Out of Tune: The Prospects for Harmonizing 
International Food Law, in Bureau of National Affairs, World Food 
Regulation Review (June 1996), 19, 21.  
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to multi-national corporations), fear that harmonization will lead 
to homogenization (or Americanization), and honest differences of 
opinion on every food regulatory subject from "lite" to 
biotechnology.
19   
 
An example of the difficulty of food harmonization is the 
long-standing controversy between the United States and the European 
Union concerning the use of hormones for growth promotion in beef 
cattle.  In early 1997, the World Trade Organization (WTO) announced 
that a draft WTO panel report had concluded that the EU Law on Imports 
of such beef violated the WTO Agreement on Sanitary and Phytosanitary 
Measures. 
 
Working in an international forum, such as Codex, can be helpful. 
 As stated above, procedures for acceptance of Codex standards, 
announced as a Reinventing Government priority in 1996, have long 
been a challenge for FDA, due to the need to compare United States 
standards with Codex standards and consider making harmonizing 
changes in the United States standards.  Shortage of FDA resources 
to do this work was a problem in the early 1970s and continues today. 
 
With respect to foods and veterinary medicine, FDA foresees the 
following as its principal activities in the area of international 
harmonization: 
 
oContinuing to participate actively in Codex Alimentarius in the 
development of international standards, to improve 
procedures for United States evaluation and, where 
appropriate, acceptance of Codex standards, and to 
facilitate public participation in that process;  
 
oPromoting international adoption of United States standards 
whenever appropriate, e.g., FDA's approach to nutrition 
labeling;
20  
 
oImproving procedures for consideration of international standards 
in FDA rulemaking, including procedures for the review 
of Codex and other international standards, guidelines, 
and recommendations with a view toward accepting those 
that provide adequate health protection;  
 
 
     
19 Id. at 20. 
     
20 See, L. Horton, International Harmonization and Compliance, 
in Nutrition Labeling and Education, R. Schapiro, Ed. (1995).  The 
Nutrition Labeling and Education Act of 1990, Public Law 101-535, 
104 Stat. 2353 (1990) gave Americans a wonderfully informative food 
label that promotes healthy eating habits.  However, it has increased 
the complexity of international harmonization for food labeling.  
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oParticipating in the Veterinary International Conference on 
Harmonization and other activities for harmonizing 
registration requirements for animal drugs; 
 
oIntensifying harmonization activities with the European Union and 
with Canada and Mexico, our North American Free Trade 
Agreement (NAFTA) partners;
21
 
oEvaluating the food inspection systems of other countries, with 
the purpose of entering into agreements with those 
countries  having  food  safety  systems  that  offer  equivalent 
levels of public health protection to those of the United 
States or that can provide assurance that their products 
will be in compliance with United States requirements;  
 
oIssuing guidance on the agency's Memoranda of Understanding (MOUs), 
particularly those finding equivalence with other 
countries' systems; 
 
oGrappling with thorny issues in several areas where there is 
controversy or disagreement as to policy, law, or both, 
such as novel foods that are the product of recombinant 
DNA biotechnology
22 and dietary supplement regulation.  
 
We at FDA see the 1990s as the beginning of an era of greater 
cooperation among food and drug health authorities around the world, 
including those of the European Union, with corresponding impacts 
on health and trade.   
 
 
V.  FDA Cooperation with the European Union on Food Regulation
23
 
For many reasons, FDA views regulatory cooperation with the European 
Union and others to be vitally important at this time.  Regulatory 
cooperation with other countries and with the European Union is a 
means of achieving our own regulatory objectives and promoting world 
public health. 
 
FDA's world has changed a lot in the last two decades, and we now 
                     
     
21 These activities include annual Trilateral meetings and efforts 
of existing technical working groups formed under the Canada/U.S. 
Free Trade Agreement concerning food additives, pesticides, food 
labeling and standards, fish products, and veterinary medicine. 
     
22 See FDA, Food Labeling: Foods Derived From New Plant Varieties, 
58 FR 25837 (April 28, 1993). 
     
23 The author is grateful to Naomi Kawin of her staff for drafting 
section V of this paper.  
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need to be much more internationally-involved than ever before.  
As discussed above, new international trade agreements demand our 
attention, and international standards have taken on new importance. 
 
Thus, we see international regulatory cooperation as a means of 
helping us achieve our core mission--domestic public health. 
 
What are the means we can use to cooperate with other countries?  
Three means of cooperation that are very important to us relative 
to the European Union are bilateral information exchange meetings, 
harmonization, and equivalence. 
 
 
 A.  Bilateral Meetings
 
FDA has been conducting bilateral meetings with the European Union's 
Directorate-General III, or DG-III, since the late 1980s.  
Directorate General III is the part of the European Commission that 
deals with industrial products, including drugs, medical devices, 
and processed foods.  Representatives of other Directorates General 
also participate in these meetings.  The meetings are generally held 
annually, most recently in Brussels in January 1997. 
 
At these meetings, FDA and the European Commission share information 
on a very wide range of common subjects of interest.  We find that 
there is great benefit in getting first-hand knowledge about what 
is happening in Europe and in developing the professional 
relationships and contacts with our European partners.  We compare 
notes on policy directions that we are taking and always find that 
we bring home new ideas. 
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 B.  Harmonization
 
The second form of cooperation with the European Union that FDA is 
engaged in is harmonization.  Harmonization is said to exist when 
two (or more) countries have a common set of requirements in place. 
 Sometimes a country must revise an existing standard to achieve 
harmonization, and sometimes harmonization can be achieved 
prospectively.  Our most successful harmonization effort to date 
has been in the pharmaceuticals area, that is, the International 
Conference on Harmonization (ICH) initiative with the European Union 
and Japan. 
 
The agency believes strongly that harmonization can and should lead 
to better consumer protection.  There is a tendency to focus on the 
trade reasons for regulatory cooperation, but in matters affecting 
health and safety, FDA believes that the public health impetus for 
regulatory cooperation needs to be the principal focus.   
 
 C.  Equivalence
 
A third form of cooperation is the United States food agencies' work 
with the European Union towards regulatory equivalence.  Equivalence 
can be said to exist when two (or more) regulatory systems are 
different, but achieve the same level of health protection.  In other 
words, the two countries may use different means to achieve the same 
level of protection against a health risk.  The WTO agreements that 
became effective last year encourage countries to work towards 
equivalence on food safety issues.   
 
FDA recently finished negotiation of three equivalence-type 
agreements with the European Union.  One agreement covers products 
that the European Union calls "veterinary products," that is, 
products--mainly foods--derived from animals such as meat, poultry, 
seafood, dairy products, and pet food.  We are also actively working 
towards equivalence in certain areas related to drugs and devices, 
as part of overall mutual recognition agreement (MRA) negotiations. 
 DG-I leads these negotiations for the EU, with technical 
representatives from DG-III.  At a summit held on May 28, 1997, 
President Clinton, for the United States, and President Santer, for 
the EU, announced that the parties had reached agreement in principle 
on these MRAs.  
 
Part of FDA’s mission is to ensure the healthfulness of products 
imported into the United States, but FDA does not have the resources 
to inspect many food firms abroad.  Consequently, we want to be able 
to rely on the results of foreign regulatory agencies' inspections 
of their firms for our own decisionmaking purposes.  If we know that 
another country's regulations are as good as ours, and if we know 
that their inspection and enforcement system is as good as ours, 
we can be assured that the products they ship to the United States 
generally attain our level of health protection.  Furthermore, if  
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we  know  which  of  the  foreign  country's  firms  are  "not  in  good  standing" 
with the foreign regulatory agency, we could look at those firms' 
imports more closely when they come to our borders, to be sure that 
they meet our standards. 
 
With respect to the veterinary equivalence discussions with the 
European  Union,  USDA  and  USTR  are  participating  in  these  discussions, 
as well as FDA.  USDA is involved because the agreements would cover 
meat and poultry, which are principally regulated by USDA. USTR and 
the trade components of USDA are involved, because there is a trade 
angle to these discussions as well as a public health angle.  In 
1992 the EU and the U.S. "settled" a trade dispute by agreeing to 
negotiate on 40 areas of difference.  (This mixing of public health 
and trade aspects has greatly complicated the negotiations and made 
it much more difficult to reach an agreement than has been the case 
in the 50 other agreements that FDA already has in place with more 
than 20 other countries.) 
 
The  proposed  veterinary  agreement  would  establish  what  we  are  calling 
a  "framework"  for  working  towards  equivalence  on  the  various  products 
covered by the agreement.  The agreement would lay out a consultation 
process that the United States and the European Union would follow 
in working towards equivalence, and it sets up various information 
exchange mechanisms, as well.  The consultation process is very 
important, since equivalence is such a new concept that there could 
be many different ways of defining it and many ways of determining 
whether two systems are indeed equivalent. 
 
Each FDA determination of equivalence will address both the 
equivalence of the foreign country's standards and the equivalence 
of the country's inspection system (including its compliance 
activities).  In addition, FDA will reach determinations of 
equivalence for only those product areas where the foreign standards 
and enforcement system assure the same (or a higher) level of health 
protection as does the United States regulatory system.  FDA will 
not  revise  its  own  standards  downward  in  order  to  achieve  equivalence. 
  
 
Furthermore, we intend to go through notice and comment rulemaking 
on each equivalence determination that we reach.  In other words, 
before declaring the seafood regulatory system of the European Union 
countries to be equivalent to that of the United States, we will 
seek public comment on the basis for our equivalence determination. 
 (This is actually required in the United States legislation 
implementing the WTO agreements.) 
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There had been hopes of having a veterinary equivalence agreement 
signed by the end of 1996.  Unfortunately, that did not happen, as 
the parties could not reach agreement on a wide range of issues.  
An agreement in principle was reached on April 30, 1997, but many 
details were still being worked out in the months that followed. 
 
 
VI.  Opportunities for Increased Cooperation
 
In sum, we at FDA have seen how cooperation with the European Union 
can help achieve public health objectives, and it might be productive 
to outline areas for increased cooperation. 
 
 A.  Strengthening Codex
 
In large part because of its recognition in the WTO Agreement on 
Sanitary and Phytosanitary Measures, Codex is attempting to 
streamline  its  standards  and  its  procedures  for  developing  standards. 
  Similarly, FDA is attempting to update its own procedures regarding 
acceptance of Codex standards, so that the agency can more easily 
accept Codex standards when they meet the agency's food safety 
requirements.   
 
FDA also is interested in improving the procedures by which Codex 
standards are developed and the transparency (openness) of the 
development process.  Regarding FAO/WHO expert committees, FDA wants 
to  ensure  that  potential  conflicts  of  interest  among  expert  committee 
members are revealed, and that the different Codex committees and 
expert committees that report to Codex follow consistent scientific 
procedures  both  in  evaluating  data  and  in  requirements  for  the  quality 
and quantity of data--so that the agency and the public can have 
greater confidence in the scientific quality of Codex standards.  
The better the quality of the science and the procedures that Codex 
uses  in  developing  standards,  the  better  the  standards,  and  the  easier 
it will be for FDA to accept them. 
 
The  European  Commission  has  already  independently  expressed  concerns 
similar to some of the ones described, suggesting opportunities for 
collaboration. 
 
 B.The Role of the International Organizations Other Than Codex 
in Food Harmonization  
 
FDA and the European Commission--and the member states--could work 
together to help define what the appropriate role should be for ISO, 
OECD,  and  environmental  programmes  in  food  harmonization  activities, 
particularly considering the tightening of agency resources to staff 
international activities (and the costs to industry of monitoring 
duplicative activities).  
 
ISO, the International Organization for Standardization, has a  
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Technical Committee on Agricultural Food Products ("TC-34").  The 
United States is neither a participant nor an observer to this group, 
and our government and industry participates in only a few working 
groups.  We do not have the resources to staff participation in this 
Committee's work. 
 
OECD is an international organization of advanced industrial 
economies that has as its aim the promotion of sustainable growth 
and employment in its members and in the world generally.
24  Together, 
FDA, the European Union, and countries at various stages of accession 
to the European Union make up a majority of the members of OECD.  
  
 
Although OECD has many useful activities, including programs on 
toxicology testing, biotechnology, and good laboratory practices 
for non-clinical studies, it is important that these programs not 
duplicate other activities already underway in other fora, e.g., 
Codex.  Also, testing guidelines need to be scientifically sound 
and realistic. 
 
A similar concern can be expressed about other international 
activities, that are attempting to cover food and drugs with blanket 
chemical hazard classification and labeling requirements unsuited 
for these products.  The Intergovernmental Forum on Chemical Safety 
(IFCS)  was  created  to  support  sound  management  of  chemicals,  improved 
coordination of related international activities, and establishment 
of a new intergovernmental mechanism on chemical risk assessment 
and management.
25  The IFCS was a product of the 1992 Rio Summit, 
the UN Conference on Environment and Development (UNCED).   
 
UNCED recommended the creation of the IFCS to pull together under 
one umbrella an earlier group--the International Programme on 
Chemical Safety (IPCS)
26 that has had a traditional role, tied to 
 
     
24 As of 1997, members are Australia, Austria, Belgium, Canada, 
the Czech Republic, Denmark, Finland, France, Germany, Greece, 
Hungary, Iceland, Ireland, Italy, Japan, Luxembourg, Mexico, the 
Netherlands, New Zealand, Norway, Poland, Portugal, South Korea, 
Spain, Sweden, Switzerland, Turkey, the U.K., and the U.S., OECD 
News Release, Pairs, May 26, 1997. 
     
25 Coordinating Group for the Harmonization of Chemical 
Classification Systems, Translation of the Technical Work of 
Harmonization of Chemical Classification and Labeling Systems into 
an International Instrument or Recommendation Applicable at the 
National Level, IOMC/HCS7/95.4Draft9.10.95. 
     
26 The IPCS is a consortium of three international 
organizations--WHO, the UN Environmental Programme (UNEP), and the 
International Labor Organization (ILO)--that is coordinated by WHO.  
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Codex, on food safety together with other organizations (OECD, FAO, 
and the UN Industrial Development Organization, or UNIDO).  
 
The six tasks set by UNCED are to expand chemical risk assessment, 
to harmonize chemical classification and labeling, to promote 
information exchange, to enhance risk reduction, to improve national 
capabilities, to prevent illegal international traffic.
27  Because 
of the role of the IPCS in supporting the scientific assessment needs 
of Codex, FDA and its European counterparts have an interest in 
assuring that the food safety activities of the IPCS that support 
Codex continue to receive support without loss of priority to 
environmental chemical issues.  It is important to guard against 
the application to foods and drugs of hazard classification and 
labeling schemes that are scientifically defective, that impose 
unnecessary costs, or both.   
 
 C.  Biotechnology  
 
The difficulties in the past two or three years due to perceptions 
about biotechnology among consumers, particularly in Europe, have 
led  to  interest  in  increasing  United  States-European  Union  activities 
on this topic.  There is generally agreement between FDA and the 
European Commission as to the science and many policy matters.  In 
particular, Commission officials agree that biotechnology is not 
in  need  of  a  special  regulatory  scheme  but  can  be  handled  in  accordance 
with established processes for approval of new foods and food 
additives, pesticides, drugs, and other products.  Within some 
European Union member states, however, the issue of biotechnology 
is extremely controversial.  These views are reflected in consumer 
organizations active in the Europe and the United States, the green 
(environmental) parties in the European Parliament,
28 and even in 
the European Council, the principal European Union legislative body. 
 
Even  putting  aside  international  organizations  such  as  OECD  and  Codex 
that have activities on biotechnology, we now have a plethora of 
bilateral fora for discussing this topic, and how to reduce public 
concern about biotechnology products that have been shown to be safe. 
 Biotechnology is discussed regularly during FDA's bilaterals with 
the European Commission, in broader United States-European Union 
consultations such as a periodic meeting known as the United 
States-European Union Biotechnology Task Force.
29  A conference under 
                     
     
27 International Organization Guidebook (1995), at 374. 
     
28 OTA Biotechnology Report, at 187. 
     
29 The New Transatlantic Agenda for the U.S. EU Summit announced 
the renewal of the mandate for this task force, which "ensures a 
continued transatlantic exchange of ideas and information in this 
rapidly changing sector."  Senior Level Report, June 12, 1996, at 
4.  
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the auspices of the Transatlantic Business Dialogue was held in April 
1997.  Additional activities are planned. 
 
The Commission's new novel foods directive is patterned in many ways 
on FDA's thinking on the subject of what requirements are appropriate 
for such foods to be placed on the market for the first time.  (Novel 
foods may not be marketed until three months after notification to 
the Commission if they meet general criteria in an annex, they are 
supported  by  scientific  data  demonstrating  safety,  and  the  Commission 
raises no objection.)  The recent difficulty has concerned the 
question of whether labeling should be required for food biotech 
generally or only in cases of possible allergens or "ethical 
concerns." 
 
 D.  Learning From European Union Harmonization Successes
 
FDA is aware of recent efforts to modernize old European directives 
on food composition that are now regarded as unduly detailed and 
prescriptive. We have a similar problem in the United States.  We 
sense that the Community's work in this area is more advanced in 
many respects than our own, and we are interested in learning more 
about it, and looking for useful models upon which to pattern our 
own regulatory changes.  An FDA Deputy Commissioner participated 
in a Commission meeting to develop a revised approach to food 
regulation, in May 1997. 
 
We are also interested in ascertaining the current status of two 
DG-III directives.  First, a 1989 General Directive on the Official 
Control of Foodstuffs describes the general standards for member 
state inspections but provided no information on the nature and 
frequency  of  inspections  or  the  follow-up  needed  in  case  of  violation, 
so that foods are removed from the market or barred entry.
30  Second, 
we understand that a 1993 amendment creates a European Union food 
inspectorate, creates a program of cooperation, sets rules for a 
mutual assistance system among member states, promotes information 
exchange on food safety problems (with confidentiality safeguards 
for commercially sensitive information), requires members' food 
laboratories to comply with European
31 and OECD standards.  More 
information  about  the  status  of  these  initiatives  would  be  of  interest 
to United States food regulators.    
 
 E.  Nutrition Labeling
 
The American public has found the FDA Nutrition Label to be useful 
                     
     
30 Council Directive 89/397, amended in 93/99 (October 1993). 
 IO Guidebook (1995) at 244. 
     
31 Council Directive 85/591 prescribes methods of analysis and 
sampling.  
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and informative in making everyday decisions about what foods to 
buy and eat.  An unexpected consequence of the popularity of the 
label is the establishment of a "bond of appreciation" between the 
agency and the ordinary consumer. 
 
Because FDA believes in the nutrition label as a valuable public 
health tool, the agency would like to promote the international 
acceptance of this approach.  The Codex guideline on the subject 
is quite old (it was modeled on the 1973 FDA regulation that our 
more recent regulation rejects), and the Codex Alimentarius 
Commission has listed nutrition labeling as a medium-term priority 
for updating.
32   
 
The EU law on nutrition labeling is based upon the Codex guideline, 
and thus upon a now-obsolete FDA regulation. 
Although the European Commission have in the past been critical of 
the FDA nutrition label requirements, FDA is hopeful that the EU 
will be willing to reconsider this label as a useful international 
model, considering the data collected on how consumers actually use 
the label in making healthy choices, how minimal the enforcement 
problems have been with it, and how grateful the consuming public 
is to FDA for requiring the label. 
 
 
 F.Agreements:  Seafood and Good Laboratory Practices (GLPs)
 
FDA and the European Commission could probably conclude an agreement 
on seafood and on many aspects of dairy products, even if the overall 
veterinary  equivalence  discussions  involving  DG-VI  (discussed  above) 
cannot be solved.  Focus on public health issues, rather than trade, 
would assist in a successful conclusion to the discussions. 
 
                     
     
32 L.R. Horton, International Harmonization and Compliance, in 
R. Shapiro, Ed., Nutrition Labeling Handbook, Marcel Dekker, Inc., 
New York, 85 (1995); C.J. Lewis, A.Randell, and F.E. Scarbrough, 
Nutrition Labeling of Foods, Comparisons Between U.S. Regulations 
and Codex Guidelines, Food Control (March 1996).  
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With respect to GLPs, both FDA and the Commission (DG-III) have 
requirements that closely resemble OECD guidelines,
33 so that rapid 
progress was expected in negotiations undertaken in 1993-94 between 
the FDA and the United States Environmental Protection Agency and 
the European Commission about a possible agreement. At first, 
substantial progress was made, before the project was set aside due 
to FDA and EPA concerns about disparities in European Union member 
states'  systems  and  a  disagreement  about  the  extent  of  FDA  inspections 
after an agreement is signed.  These negotiations could be resumed, 
after the successful completion of the ongoing pharmaceutical good 
manufacturing practices negotiations in which similar issues have 
arisen.  Alternatively, current multilateral arrangements in OECD 
on GLPs may make a bilateral U.S.-EU GLP agreement unnecessary.   
 
Participation by public health-oriented officials from the 
Commission or member states in the GLP discussions would have 
facilitated a successful conclusion of this negotiation. 
 
Meanwhile, bilateral MOU's have been entered between FDA and five 
European  Union  member  states  (France,  Germany,  Italy,  the  Netherlands, 
and the United Kingdom).  At present only the European Commission 
has authority to negotiate new MOUs.  
 
 G.  New Emerging Concerns
 
As the 1990s draws to a close, it may be advisable for FDA and the 
European Union to strengthen their capacity to deal with new food 
safety concerns of all types, as they arise.  Examples are 
coordination of research and regulatory activities concerning BSE, 
endocrine disruptors (evidence that certain synthetic and naturally 
occurring  organic  chemicals  might  affect  female  and  male  sex  hormones 
and thus human cancers
34), and spread of food borne illness due to 
microbial  contamination  and  hygiene  problems  in  the  country  of  origin. 
  
 
On the issue of new emerging and reemerging diseases, in June 1996, 
as part of the New Transatlantic Agenda, the United States and the 
European Union announced the establishment of a United 
States-European Union Task Force on Communicable Diseases to build 
a global early warning and response network for such diseases to 
                     
     
33 OECD Council Recommendation on Compliance with Principles 
of Good Laboratory Practice C(89)87(Final); OECD Council Decision 
C(81)30(final).  The GLP approach is more stringent and specific 
than those of ISO Guide 25 on laboratory accreditation. 
     
34 P. Fenner-Crisp, EPA, "Incorporating New Science into 
Environmental Health Risk Decisions," at the Chemical Industry 
Institute of Toxicology meeting, April 30, 1996; Food Chemical News, 
vol. 38, no. 12 (May 13, 1996), at 31-32.  
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facilitate decisive joint activities to curtail the health threats 
of the future.
35
 
 H.  Technical Assistance Coordination
 
A pressing priority, recognized in one international meeting after 
another, is for developing countries to improve the safety of water 
and  foods  produced  for  their  own  consumption,  as  well  as  food  exports. 
 Also, the European Union and the United States should help promote 
implementation of HACCP in other countries, and particularly 
developing countries.   
 
We should regularly exchange information about technical assistance 
efforts, either to collaborate or to avoid duplication.  For example, 
FDA has recently embarked on a cooperative activity with India to 
improve  the  safety  and  quality  of  its  shrimp,  much  of  which  is  rejected 
by FDA due to failure to meet agency requirements.  Earlier, we helped 
Brazil to reduce salmonella contamination of pepper. 
 
 
VII. Conclusion
 
As the 20th century draws to a close, we can see that, at the very 
time when resources are shrinking, international harmonization 
activity needs to intensify and food regulators in developed 
countries such as the United States and the European Union must also 
confront new challenges (such as products derived from recombinant 
DNA biotechnology, unique food additives such as Olestra, and the 
ever-present issue of dietary supplements.)  Even older technologies 
increase the difficulty of harmonization.  The sheer numbers of 
individual substances for use in food or processes for food 
(pesticides, veterinary drugs, aids in processing, direct food 
additives, irradiation technologies, and food packaging materials) 
-- and the tendency of FDA and other advanced regulatory agencies 
to make decisions on these substances on an individual, one-by-one 
basis -- magnify the number of decisions lacking international 
uniformity. 
 
Despite the challenge, much progress has been made.  FDA believes 
that the groundwork is being laid for more progress, in bilateral 
discussions between the United States and the European Union and 
in international settings such as Codex Alimentarius.  
 
 
                     
         
35  President  William  Clinton,  Press  Conference  by  President  Clinton, 
President  Santer  of  the  European  Commission,  and  Prime  Minister  Prodi 
of Italy, June 12, 1996, at 2; New Transatlantic Agenda, Senior Level 
Group Report to the U.S.-EU Summit, June 12, 1996, at 2.  
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Appendix 1.Other United States Food Agencies (Besides FDA and USDA)
 
 A.    EPA
 
EPA registers pesticides and establishes pesticide tolerances that 
are enforced by FDA and FSIS.  EPA has extensive international 
activities in the pesticides area, particularly under the auspices 
of the International Programme on Chemical Safety under the United 
Nations Environmental Programme, FAO, WHO, Codex Alimentarius, and 
OECD.   
 
 B.    BATF
 
Regulation of alcoholic beverage standards and labeling generally, 
and product names particularly, are generally handled by the Bureau 
of Alcohol, Tobacco, and Firearms (BATF) of the Department of the 
Treasury.    FDA  approves  additives  used  in  these  beverages  and  enforces 
EPA tolerances for pesticide residues in them. 
 
  
C.  Fee-for-Service Agencies
 
Commercial needs have led to the creation of fee-paid voluntary 
grading and inspection services for exports, even for those food 
products (other than meat, poultry and egg products) that are 
regulated principally by FDA.  Such programs are administered by 
USDA's Agricultural Marketing Service (AMS) under the Agricultural 
Marketing Act of 1946,
36 the Federal Grain Inspection Service (FGIS), 
and the Department of Commerce's National Marine Fisheries Service 
(NMFS).  
 
Appendix 2.  Early United States Food and Drug Laws
 
 A.  Colonial Era
 
English common law applied in the American colonies, and early 
colonial legislatures, starting with Massachusetts in 1784, 
practiced a form of international harmonization in that they passed 
food protection laws imitating those of the mother country.
37  British 
enactments had begun as early as the 1203 Assize of Bread, which 
prohibited adulteration of bread with cheap ingredients,
38 leading 
                     
     
36 60 Stat. 1082 (1946), 7 U.S.C. § 1622. 
     
37 The General Laws and Liberties of the Massachusetts Colony 
17 (1672 ed.), Wallace F. Janssen, "America's First Food and Drug 
Law,"  30 Food, Drug, Cosmetic Law Journal 665 (1975).  
     
38 FDA Backgrounder, Milestones in U.S. Food and Drug Law History; 
Peter Barton Hutt, Government Regulation of the Integrity of the  
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eventually to parliamentary passage in 1860 of the first nationwide 
general food law of modern times.
39   
 
 B.  State Laws
 
After United States independence, state governments carried over 
such laws,
40 but 130 years passed before the first comprehensive 
national law--the Food and Drugs Act of 1906
41--was enacted.   
  
  
C.  Early National Laws
 
When Congress begun to pass laws that recognized the need for Federal 
food safety controls, it initially focused upon laws directed toward 
potentially hazardous imports or exports, or both, due to the 
existence of some controls at the State level over domestic food. 
Early national laws included: 
 
oThe Drug Importation Act, of 1848;
42
 
oThe Food and Drug Importation and Exportation Act of 1890;
43
 
oThe Food Importation Act of 1899
44
 
  o  The Tea Importation Acts of 1893 and 1897 (repealed in 
  1996). 
  
Early legislators believed that exporters in other countries, 
particularly European countries, were dumping substandard and, in 
some  cases,  dangerous  food  and  drug  products  upon  the  growing  American 
market.
45  Of course, State governments were ill-equipped to screen 
                                                                  
Food  Supply,  4  Annual  Review  of  Nutrition  1  (1984),  in  Hutt  and  Merrill, 
Food and Drug Law:  Cases and Materials, at 2-3. 
     
39 Wallace F. Janssen, "The U.S. Food and Drug Law:  How it Came, 
How it Works, a reprint from FDA Consumer magazine. 
     
40 23 and 24 Vict., c. 84 (1860). 
     
4134 Stat.768, June 30, 1906. 
     
42 9 U.S. Stat. 237, June 26, 1848. 
     
43 26 Stat. 414, August 30, 1890. 
     
44 30 Stat. 951, March 1, 1899. 
     
45 James Harvey Young, Pure Food:  Securing the Federal Food 
and Drugs Act of 1906, Princeton University Press, Princeton, N.J., 
1989, at 1-17.  See the international harmonization chapter on drugs  
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imports, both legally and practically:  the United States 
Constitution assigned to the Congress, not the states, the task of 
regulating interstate and foreign commerce, and the concentration 
of product entries in a few ports, particularly New York, overwhelmed 
local authorities.
46   
 
The focus of these early national laws upon imports or exports, or 
both--rather than food generally--was based, not on a discriminatory 
rationale, but rather on views that the Constitution assigned to 
states the task of maintaining adequate control of domestic 
production or that, even if Federal action was constitutional, state 
action was adequate.  As the country became more urban and 
industrialized, and less agrarian, views began to change.  By the 
beginning of the 20th century, there had developed a widespread 
conviction that nationwide, Federal action to assure that food and 
drugs are neither adulterated nor misbranded was both constitutional 
and necessary.
47  Federal laws were seen as girding the strength of 
State measures that had also, a few years earlier, been upheld as 
a constitutional exercise of State police power.
48
 
 D.  International Influence Upon Harvey Wiley
 
An international aspect of FDA's early history was that Harvey 
Washington Wiley may never have come to Washington in 1883 to become 
Director of FDA's predecessor, the Bureau of Chemistry, had he not 
been influenced by food safety research underway in Europe.   
 
In 1878, when Dr. Wiley had moved from practicing medicine to serving 
as a chemistry professor at Purdue University in Indiana, he asked 
for a one-year leave of absence in order to study how laboratory 
research was being conducted on sugar in Vienna, Berlin, Bonn, 
                                                                  
and biologics, of the companion volume of this treatise on Food and 
Drug Law, for a discussion of the problems that led to the Drug 
Importation Act of 1848. 
     
46 Id. 
     
47 Mitchell Okun, Fair Play in the Marketplace: The First Battle 
for  Pure  Food  and  Drugs,  Illinois:  Northern  Illinois  University  Press 
(1986).  Hipolite Egg Co. v. United States, 22 U.S. 45 (1911); 
McDermott v. Wisconsin, 228 U.S. 115, 128 (1913). 
     
48 Id. 13, 164.  In Plumley v. Massachusetts, 155 U.S. 461 (1894), 
the Supreme Court upheld the constitutionality of a state 
oleomargarine law under "the acknowledged power of the States to 
protect the morals, the health, and safety of their people" including 
"the protection of the people against fraud and deception in the 
sale of food products." Id. at 479.  See also Crossman v. Lurman, 
192 U.S. 189 (1904).  
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Heidelberg, and Leipzig.
49  Dr. Wiley returned to the United States 
with a new passion for examining food products and a firm decision 
to abandon medicine altogether in order to concentrate upon the study 
of food adulteration.
50   
 
Drawing upon what he learned in Europe, Dr. Wiley applied himself 
to research on the adulteration of honey with glucose and to related 
work on sugar, earning such national recognition as an expert that 
he attracted the attention of political leaders in Washington. 
 
Not long after, Dr. Wiley was appointed in 1883 as Chief Chemist 
in the Bureau of Chemistry in the United States Department of 
Agriculture.
51  And his interest in international collaboration did 
not  cease:    agency  records  show  that  Dr.  Wiley  traveled  to  a  conference 
in Geneva in 1908 on the subject of food regulation.
52
 
Considering the critical role of Dr. Wiley in laying the scientific 
and administrative framework for what later became FDA, and in 
securing the passage of the 1906 Act, that 1878 trip to Europe in 
search of international answers to United States problems had an 
undeniable impact upon the birth of modern United States food and 
drug law and the agency itself!   
 
The  Bureau  of  Chemistry  under  Dr.  Wiley's  leadership  dedicated  itself 
to research on food adulteration (including tests done on human 
volunteers known as the Poison Squad) and building support for a 
comprehensive food and drugs law. 
 
 
     
49 Suzanne Rebecca White, Chemistry and Controversy: Regulating 
the Use of Chemicals in Foods, 1883-1959, in partial fulfillment 
of the requirements for a Ph.D., Emory University, Georgia (1994), 
at 4. 
     
50  Id. This early international influence thus shaped FDA:  
were it not for his European studies, would Dr. Wiley have remained 
an Indiana physician? 
     
51  Id. at 25. 
     
52  Dr. Wiley Goes to Geneva, FDA Scrapbook [on file in FDA History 
Office, Rockville, MD].  
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 E.  An English Model for What Became the Food and Drugs Act 
As discussed above, during the last quarter of the 19th century, 
public support grew for enactment of a national food and drug law. 
 And those who think that international harmonization was only a 
recent priority of FDA may be surprised to learn that the landmark 
Food and Drugs Act of 1906 was the product of an international 
harmonization endeavor! 
 
In 1881, amid growing publicity about the use of dangerous substances 
in food and other products, the United States National Board of Trade 
sponsored a contest for drafting a proposed food and drug law.
53  
The winner of the first prize, Dr. G.W. Wigner, was a public policy 
analyst in England who was knowledgeable about the English laws
54 
and who had reviewed existing law from around the world.  A bill 
based upon his draft was the first to use the term "adulteration" 
and the first to cover both food and drugs.
55  In 1888 bills began 
to prohibit "misbranding," a term that was embraced to capture the 
notion of "false trade description" in the English antecedent, the 
British Merchandising Marks Act of 1887.
56  The purpose of these 
provisions was to prevent the passing off of food or drugs falsely 
labeled  or  branded  or  otherwise  represented  to  be  of  standard  quality, 
strength, or purity when they were not.   
 
Thus, the key statutory concepts of "adulteration" and "misbranding" 
found their way from the mother country to ours, more than a century 
after independence. 
 
                     
     
53  Litman, R.C., and Litman, D.S., "Protection of the American 
Consumer:  The Congressional Battle for the Enactment of the First 
Federal Food and Drug Law in the United States," 37 Food Drug Cosmetic 
Law Journal, 310, 313 (1982). 
     
54  Id. 
     
55 Combination of food and drug law in the same basic legislation 
is more often seen in countries that once were British colonies than 
in other countries.  J.G. Zimmerman, "Food Law--International," 31 
Food Drug Cosmetic Law Journal 218, 222 (April 1976).  For example, 
a  1976  German  law  covered  foods,  tobacco,  cosmetics,  and  other  objects 
that come in non-casual contact with the human body but not 
pharmaceuticals.  Id. 
     
56 Litman and Litman, supra note 53 at 315.  
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 F.  The Food and Drug Importation Act of 1899
57  
 
The first legal mandate for the Bureau of Chemistry arrived as an 
obscure provision in its appropriations for the year 1900 that 
authorized the investigation, through inspection and analysis, of 
the adulteration of foods, drugs, and liquors and to bar entry of 
imports "which are dangerous to the health of the people of the United 
States."
58      
 
A 1903 Act added two new categories of forbidden imports, those 
bearing false labels and those forbidden or restricted from sale 
within the nation from which they had been shipped.
59  Similar 
provisions are found today in the Federal Food, Drug, and Cosmetic 
Act. 
 
United States Customs worked out a cooperative arrangement with the 
Bureau of Chemistry to conduct the necessary analytical work to 
ascertain whether to admit the products into the United States.  
After  the  enactment  of  the  1899  Act,  the  Bureau  established  six  import 
laboratories in major ports (Boston, Chicago, New Orleans, New York, 
Philadelphia, and San Francisco) and began to enforce the 1899 law.
60 
 Thus, the Bureau had experience and infrastructure that later was 
helpful after Congress passed the Food and Drugs Act of 1906.   
 
 G.  The Food and Drugs Act of 1906
 
At last the Congress enacted the landmark Food and Drugs Act of 1906, 
which outlawed the adulteration or misbranding of food and drugs. 
 
 H.  Early Meat Inspection Laws
 
The popular view that Upton Sinclair's The Jungle led to the first 
United States meat inspection laws is an oversimplification, as 
United States export interests were the first incentive for Federal 
action. 
 
The 1890 Food and Drug Importation and Exportation Act,
61 and its 
                     
     
57  Id.  at 164. 30 Stat. 951, March 1, 1899. 
     
58 Id. at 164. 30 Stat. 951, March 1, 1899. 
     
59 Id. 
     
60 "The United States ceased to be a dumping ground for shoddy 
foods and liquors sent from abroad," and "[n]o importers took one 
of the bureau's restrictive decisions to court."  James Harvey Young, 
Pure Food, at 164. 
     
61 26 Stat. 414, August 30, 1890.  
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later refinements,
62 contained regulatory provisions used by FDA's 
predecessor, the Bureau of Chemistry in the then Department of 
Agriculture to bar entry of adulterated food and drugs, and it also 
gave that Department's Bureau of Animal Industry--predecessor to 
both FSIS and APHIS--authority to inspect meat exports and imports. 
 
Of interest is that the principal motivating factor in Congressional 
enactment of this law was response to European demands concerning 
animal quarantine and meat hygiene requirements.
63  European 
requirements were based, to some degree, upon a genuine concern about 
the safety of United States meat as well as upon a protectionist 
response to cheap United States meat shipments from the power packing 
houses of Armour and Swift.  Scare stories about trichinae from 
American hogs and pneumonia in cattle led to a wave of embargoes 
against United States meat.
64
 
Congress did not accept European doubts about the safety of United 
States exports but, seeing an opportunity to expand annual exports 
by $50 million, decided pragmatically to pass an inspection law to 
increase confidence in the products.
65
 
 
     
62 26 Stat. 1089 (1891). 
     
63 James Harvey Young, Pure Food, at 130-35.  U.S. Trade 
Representative, USDA, and FDA participants who, as of 1996, are 
growing weary of discussions with the European Commission's 
Directorate General VI about its directives' hygiene 
requirements--or about the E.U.'s continued ban on meat from 
hormone-treated animals--will draw scant comfort in knowing that 
the U.S. has been trying for more than a century to satisfy European 
demands concerning U.S. meat!  
         
64  James  Harvey  Young,  Pure  Food,  at  131.    Germany,  Italy,  Portugal, 
Greece,  Spain,  France,  Austria-Hungary,  Turkey,  Romania,  and  Denmark 
excluded U.S. pork products wholly or in part.  While Great Britain 
did not embargo U.S. meat, its imports fell sharply.  See John L. 
Gignilliat, "Pigs, Politics, and Protection:  The European Boycott 
of American Pork," Agricultural History 35 (1961), 3-12; Louis L. 
Snyder, "The American-German Pork Dispute, 1879-1891," Journal of 
Modern History 17 (1945), 16-28. 
     
65 Id. at 132.  
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The 1890 law forbade export or import of infected cattle and the 
export of unwholesome meat, authorizing the "careful inspection" 
(meaning microscopic examination for trichinae) of pork for export.
66 
 When other countries protested that the inspection did not include 
the condition of the hog at the time of slaughter, Congress in 1891 
expanded the law to require mandatory antemortem inspection for all 
live cattle, hogs, and sheep.
67  Carcasses and products intended for 
export also were required to be inspected.  The law authorized 
inspection of meat in interstate commerce, but as no funds were 
appropriated  for  this  provision,  it  was  not  implemented,  and  domestic 
coverage awaited the Federal Meat Inspection Act of 1906.  European 
reaction to the American measures was mixed: 
 
Representatives from European states came to observe American 
procedures, and shortly restraints on the acceptance of pork 
abroad  were  abandoned  or  relaxed.    Sales  soared,  by  1895  reaching 
their preembargo high. ... [However,] in an effort to assure 
themselves of avoiding trichinosis while continuing to eat raw 
pork, Germans, through their local governments, set up an 
extensive network of microscopists, an inspectional army, in 
fact, larger in number than the entire enlisted ranks of the 
United States Army at the outbreak of the Spanish-American War. 
 The German states insisted on reinspecting imported American 
pork, charging such high fees as virtually to price it out of 
the market.
68
 
By sending to Berlin in 1898 a highly competent zoologist, armed 
with a microscope, as United States agricultural attache, the United 
States countered German concerns and in the process identified weak 
spots in both the United States export control system and the German 
states' import control systems.
69   Germany nevertheless eventually 
called off its pork embargo.  By then, however, the "embalmed beef" 
scandals of the 1898 Spanish-American War had generated United 
States' concern about its own meat, another stimulus to the 1906 
meat law that predated The Jungle.
70  This book also was an important 
factor in the enactment of the 1906 Meat Inspection Act, which 
provided uniform coverage for United States meat intended for 
                     
     
66 James Harvey Young, Pure Food, at 133. 
     
67 26 Stat. 1089, March 3, 1891.  In 1895, the law was further 
strengthened.  28 Stat. 727, March 2, 1895.   
     
68 Young at 133-34. 
     
69 Id. Charles Wardell Stiles, the American attache, had trained 
in Germany. 
     
70 Id. at 130, 135.  
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domestic markets and  provided for enforcement.
71   
 
I.  The 1938 Act and World War II
 
The Federal Food, Drug, and Cosmetic Act of 1938
72 modernized the 
Food and Drugs Act of 1906.  The agency obtained explicit authority 
to conduct inspections, establish food standards and issue other 
regulations, and set tolerances for poisonous or deleterious 
substances. 
 
When President Franklin Roosevelt moved FDA from the Department of 
Agriculture  to  the  new  Federal  Security  Agency  in  1939,  international 
considerations influenced his decision to let the meat inspection 
program  under  Agriculture.    With  clouds  of  war  on  the  European  horizon, 
the fear was expressed that reorganizing United States meat 
inspection into an unknown agency might dampen European confidence 
in the safety of United States beef at the very time that demand 
for United States meat shipments was expected to rise due to 
diminished capacity in war-torn Europe to meet Allied needs. 
 
 
Appendix 3.  Organization of Food Regulation in Other Countries
 
Despite widely shared beliefs in the importance of food safety 
regulation, differences in regulatory approaches abound, even in 
highly developed countries in Europe and North America.  In developed 
countries and even many middle-income and developing countries, food 
regulatory  functions  are  commonly  dispersed  among  separate  agencies. 
 Few countries have managed to place food authority in one agency. 
 
FDA believes strongly that its placement in the United States 
Department of Health and Human Services, rather than in the 
Agriculture  Department,  has  helped  it  to  maintain  its  vigilant  public 
health orientation over the years.  The President's and Vice 
President's first report on Reinventing Government, issued in 1993, 
recommended that United States food regulatory programs be brought 
together  under  FDA.    (Congressional  proponents  of  retaining  the  meat, 
poultry and egg products programs in USDA promptly responded by 
enacting legislation to create a new position of Undersecretary for 
                     
     
71 Sinclair had said there was never any inspection of meat after 
slaughter, "except the meat intended for export to Germany, France, 
and England, where the laws were enforced;" the charge led President 
Theodore Roosevelt to establish an investigative commission whose 
report also supported new legislation.  Litman, R.C., and Litman, 
D.S., Protection of the American Consumer:  The Congressional Battle 
for the Enactment of the First Federal Food and Drug Law in the United 
States, 37 FDCL Journal, 310, 325 (1982). 
     
72  52 Stat. 1040 (1938).  
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Food Safety that would be kept separate from the production- and 
trade-oriented parts of the Department.) 
 
Although thwarted in its reorganization proposal, the Clinton 
Administration has achieved many of its desired regulatory and 
philosophical reforms at USDA, by rulemaking that is moving meat 
and  poultry  inspection  to  a  more  modern,  risk-based  inspection  system 
founded on the principles of Hazard Analysis Critical Control Points 
(HACCP), and by sending seasoned FDA officials to serve as 
Administrator, FSIS, and as Acting Undersecretary for Food Safety. 
 Most importantly, FDA and FSIS are working together as never before 
on  a  wide  range  of  activities  in  the  area  of  food  safety,  food  labeling, 
and international harmonization. 
 
Questions have arisen as to whether the U.S. government has ever 
considered creating a separate food agency, independent of any 
existing Department (along the lines of EPA).  The answer is that 
very little consideration has been given to this idea.   
 
The other question asked is whether consideration has been given 
to removing FDA, in its entirety, from DHHS.  The answer is, yes, 
in  1972  the  Senate  passed  a  bill  that  would  have  created  an  independent 
Food, Drug, and Consumer Product Agency.  The House preferred to 
leave  FDA  in  DHEW  and  to  create  an  independent  Consumer  Product  Safety 
Commission.  The House view prevailed.  Later in the 1970s, Senator 
Kennedy espoused a "Drug and Device Agency" and a separate "Food 
Agency" that would have included veterinary medicine functions.  
These ideas did not get very far. 
 
The placement of meat and poultry in an agriculture-oriented agency 
is not unusual.
73  The concern is that such a placement may tend to 
create conflict of interest situations (such as the current BSE 
situation in Europe).  In France, the UK, and Ireland, most or all 
of the food regulatory responsibilities are under the agriculture 
ministry.  Recently questions have been raised about whether the 
assignment of food regulatory responsibility in this way creates 
a potential for conflict of interest when there arises a food borne 
hazard such as BSE.  The issue is whether a ministry that is 
responsible for both agribusiness and consumer protection can do 
justice to that latter when there is a threat to the former.  Serious 
questions are being asked about whether adequate steps were taken 
to contain the spread of the disease and to inform the public and 
high governmental officials, of the possible risks at hand. 
 
Prior to a recent decision to move certain of its food safety programs 
 
         
73    One  reason  for  such  placement  is  that  control  of  animal  diseases, 
a function aimed at protecting agricultural production resources, 
tends to be placed in ministries of agriculture and also involves 
meat issues.  
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to DG-XXIV, Consumer Protection, the European Commission had placed 
most  food  regulatory  responsibility  in  DG-III,  Industry,  but  assigned 
to  DG-VI,  Agriculture,  the  handling  of  veterinary  products  (including 
seafood), the traditional foods program (to give special protection 
to traditional appellations like "Parma ham," "feta cheese," and 
the like), and economic regulatory issues related to the Common 
Agricultural Program.
74  Placement of the meat and poultry inspection 
programs in agriculture ministries also tends to attract more 
resources-- particularly when there are requirements for antemortem 
inspection and continuous inspection of processing--and might be 
a factor in the availability of much fewer resources for the 
regulation  of  the  foods  that  make  up  most  of  the  diet  in  most  countries. 
  
 
Granted, meat and poultry are inherently more risky than many other 
foods, but objective risk-based decisions would certainly result 
in a reallocation of some resources to high-risk foods other than 
meat and poultry (e.g., seafood, eggs, dairy products, reduction 
of problems of lead or aflatoxin contamination, microbial risks in 
already-prepared foods, fruits and vegetables that might contain 
disease-causing  organisms,  and  improperly  canned  food).    Furthermore, 
increased  resources  are  needed  in  the  United  States  and  many  countries 
to increase inspectional frequency for firms processing foods 
generally.  
 
To discuss a few other variations in the organization of food 
regulation, some countries place seafood inspection under the 
agriculture agency responsible for meat inspection (Australia, New 
Zealand, France, UK), while the United States placed it under FDA 
as the health agency responsible for food generally.  Still other 
countries  have  a  separate  fisheries  ministry,  often  with  conservation 
and trade responsibilities as well (Chile, Uruguay, and Thailand). 
  
 
Another factor in organizing food agencies is conserving resources, 
aimed at allowing personnel cuts, minimizing overlap, and 
strengthening  coordination.    Canada  has  created  a  new  Food  Inspection 
Agency that will combine forces from its ministries of health, 
fisheries, and particularly agriculture.  The health ministry will 
write many of the standards for foods generally that will be enforced 
by the new agency.  (The description is that Health Canada will serve 
as the brains of food regulation while the new inspection 
agency--comprised largely of inspectors from the ministries for 
agriculture and fisheries--will serve as the limbs.)   
 
 
     
74 The European Commission's DG-VI and the Australian Quarantine 
and Inspection Service (APHIS) combine the animal health aspects, 
and the human health aspects, of meat regulation into one agency.  
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Appendix 4.  FDA Standards Policy. 
 
  On October 11, 1995, World Standards Day,
75 the Food and Drug 
Administration published a policy entitled, "International 
Harmonization; Policy on Standards."
76  In this document, FDA 
described the agency's policy on the development and use of standards 
with respect to international harmonization of regulatory 
requirements and guidelines: 
 
  It is the intent of this policy to enable FDA to:   
 
  (1)  Continue to participate in international standards 
activities that assist it in implementing statutory provisions 
for safeguarding the public health,  
 
  (2) increase its efforts to  harmonize its regulatory 
requirements  with  those  of  other  governments,  including  setting 
new standards that better serve public health, and  
 
  (3) respond to laws and policies such as the Trade Agreements 
Act [19 USC 2531-82] and OMB Circular No. A-119 that encourage 
agencies  to  use  international  standards  that  provide  the  desired 
degree of protection.   
 
 Accordingly,  it  is  the  policy  of  FDA,  concerning  the  development 
and use of standards, that: 
 
  A.  FDA participation in standards development will be based 
on the extent to which the development activity and expected 
standard conform to certain factors, with consideration also 
being given to the resources available in FDA to devote to the 
effort and expected efficiencies to be gained as a result of 
the effort; the factors are as follows: 
 
  1.  The standard stresses product safety and effectiveness 
and therefore contributes to safe, effective, and high quality 
products; when necessary, the standard also covers all factors 
required to ensure safety and effectiveness, including product 
 
     
75 World Standards Day commemorates the founding of the 
International Organization for Standardization (ISO) on October 14, 
1946.  In the U.S. its 49th anniversary was October 11, 1995. 
     
76 Federal Register of October 11. 1995 (60 FR 53078).This policy 
document  does  not  create  or  confer  any  rights,  privileges,  or  benefits, 
for or on any person, nor does it operate to bind FDA in any way. 
 In the Federal Register of November 28, 1994 (59 FR 60870), FDA 
published a draft policy and invited public comment, and in the 
October 11, 1995 document, FDA responded to comments received.  
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and process design, and process performance; 
 
  2.  The standard is based on sound scientific and technical 
information and permits revision on the basis of new 
information; 
 
  3.   The development process for the standard is transparent 
(i.e., open to public scrutiny), complies with applicable 
statutes, regulations, and policies, specifically including 
[21 CFR] § 10.95 and OMB Circular A-119, and is consistent with 
the codes of ethics that must be followed by FDA employees; 
 
  4.   The  development  of  an  international  standard  that    achieves 
the agency's public health objectives is generally, but not 
always, given a higher priority than the development of a 
domestic standard; and 
 
  5.   The development of a horizontal standard which applies 
to multiple types of products is generally, but not always, 
given higher priority than the development of a vertical 
standard which applies to a limited range of types of products. 
 
  B.   FDA is not bound to use standards developed with FDA 
participation.  For example, the agency will not use a standard 
when,  in  the  judgment  of  FDA,  doing  so  will  compromise  the  public 
health. 
 
  C.   The uses of final (and selected draft or proposed) 
standards, or selected relevant parts, will include, where 
appropriate:   
 
  (1)Incorporating such standards into guidance documents for 
nonclinical testing, applications for conducting 
clinical trials with investigational products, and 
applications for permitting products to be marketed;   
(2)  conducting reviews of such applications;  
 
(3)incorporating such standards into compliance policy guides;  
 
(4)conducting reviews of test protocols used by firms as part of 
good manufacturing practices;  
 
(5)conducting reviews of study protocols submitted by firms as 
required for postmarket surveillance studies or 
programs;  
 
(6)serving as the basis for mandatory standards or other regulations 
promulgated by FDA; and (7) serving as the basis for 
reference  (e.g.,  evaluation  criteria)  in  a  memorandum 
of understanding with other government agencies.  
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D.The  use  of  a  standard  in  the  regulatory  programs  of  FDA    is  dependent 
upon the following factors: 
  
  1.  The standard stresses product safety and effectiveness 
and therefore, if adhered to, would help ensure the safety, 
effectiveness, or quality of products; when necessary, the 
standard also covers all factors required to ensure safety and 
effectiveness, including product and process design, and 
process performance; 
 
  2.  The standard is based on sound scientific and technical 
information and is current; 
 
  3.  The development process for the standard was transparent 
(i.e., open to public scrutiny), was consistent with the codes 
of ethics that must be followed by FDA employees, and the 
standard is not in conflict with any statute, regulation, or 
policy under which FDA operates; 
 
  4.  Where a relevant international standard exists or 
completion is imminent, it will generally be used in preference 
to a domestic standard, except when the international standard 
would be, in FDA's judgment, insufficiently protective, 
ineffective, or otherwise inappropriate; and 
 
  5.  Where a relevant horizontal standard which applies to 
multiple  types  of  products  exists  or  its  completion  is  imminent, 
it will generally be used in preference to a vertical standard, 
which applies to a limited range of types of products, except 
when such horizontal standard would be insufficiently 
protective, ineffective or otherwise inappropriate. 
 
  E.  FDA employees will comply with agency regulations ([21 
CFR] § 10.95) covering participation in standard setting 
activities outside the agency. 
 